Skip to main content
UniHealth

Doctor search

Matilda F Chan, MD

Ophthalmology · San Francisco

NPI 1245334606

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
9
1 carrier
Offices
5
Since medical school
24 years
Graduated 2002

Offices

5 locations · UCSF Medical Group Business Services · Regents of the University of California · University of California Sfgh Medical Group

Looking this up.

Hospitals listed: UCSF Medical Center · Zuckerberg San Francisco General Hosp & Trauma Ctr. That is not proof they admit you there this week.

Plans that list them

9 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chan’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026

California Medical Board record

Licence A95474 · Current

Licensed to practise in California · since 2006 · expires 2027-11-30 · University of Southern California Keck School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Ophthalmology - Ophthalmology

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
  • Zuckerberg San Francisco General Hosp & Trauma CtrSan Francisco, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of San Francisco Health Network, which runs 2 hospitalsPatients rate it 3 of 5 · 72% would definitely recommend it
    Overall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.449, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.37, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.538, Oct 2024 – Sep 2025
See every measure and the patient survey for UCSF Medical Center

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at UCSF Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.9 (3.79 to 6.02) · 7,590 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.8 (11.3 to 14.4) · 2,019 casesWorseJan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths139.4 (110.22 to 168.58) · 452 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.622BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.626BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.491BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.7 to 1) · 2,336 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.24 (0.58 to 1.9) · 4,689 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.05 (0.89 to 1.2)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.9 · 89 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.5 · 85 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.1 · 132 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.6 · 454 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 618 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 380 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.7 · 5,000 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.22 (0.06 to 0.38) · 15,965 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.05 to 0.35) · 17,859 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.85 (0 to 1.83) · 4,184 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2 (1.1 to 2.9) · 6,516 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.35 (4.49 to 10.21) · 3,989 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5 (3.22 to 6.77) · 4,087 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.95 (0.74 to 3.15) · 2,034 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.95 (0.63 to 1.28) · 15,431 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 399 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.899No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.689No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.224No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16 · 156 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20 · 564 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits60.3 · 160 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-9.7 · 550 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits44.1 · 660 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 667 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.7 (4.8 to 6.7) · 2,019 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6 · 421 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 53 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 107 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.9 (11.3 to 17.1) · 3,247 casesNo differentJan 2022 – Dec 2024

What patients said (3,181 patients answered, 25% of those asked)

Patient survey stars by topic at UCSF Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at UCSF Medical Center
Room was "always" clean71%
Nurses "always" communicated well80%
Doctors "always" communicated well80%
Staff "always" explained61%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully78%
Nurses "always" treated them with courtesy and respect86%
"Always" quiet at night50%
"YES", patients would definitely recommend the hospital81%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Zuckerberg San Francisco General Hosp & Trauma Ctr

Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Zuckerberg San Francisco General Hosp & Trauma Ctr
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.449BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.37BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.538BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.9 (0 to 1.91) · 667 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.12 (0.76 to 1.49)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths195.34 (147.34 to 243.34) · 76 casesNo differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths7.2 · 114 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.2 · 48 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths7.5 · 201 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.5 · 214 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.3 · 261 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.5 · 1,351 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.29 (0.07 to 0.5) · 4,709 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.39 (0.19 to 0.59) · 4,644 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.34 (2.11 to 6.56) · 795 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.59 (0 to 3.28) · 234 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.85 (1.33 to 4.38) · 861 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.95 (0.25 to 17.64) · 261 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6 (2.01 to 9.98) · 242 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.66 (0.17 to 3.14) · 167 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.79 (0.08 to 1.49) · 4,129 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.4 · 35 casesNoneApr 2023 – Mar 2025
MRSA BacteremiaInfections0.709No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.769No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.7 · 41 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22.1 · 227 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits28.6 · 257 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits75.1 · 239 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.2 · 232 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 175 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits11.3 (8.3 to 15.1) · 175 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.1 · 37 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.2 · 132 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.6 (10.4 to 17.9) · 966 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.2 (0.8 to 1.7) · 88 casesNo differentJan 2024 – Dec 2024

What patients said (1,644 patients answered, 16% of those asked)

Patient survey stars by topic at Zuckerberg San Francisco General Hosp & Trauma Ctr
Cleanliness4
Nurse communication2
Doctor communication3
Communication about medicines2
Discharge information3
Overall hospital rating4
Quietness3
Recommend hospital4
Share of patients giving the best answer at Zuckerberg San Francisco General Hosp & Trauma Ctr
Room was "always" clean69%
Nurses "always" communicated well73%
Doctors "always" communicated well75%
Staff "always" explained56%
Yes, staff "did" give patients this information84%
Yes, staff "did" give patients information about help after discharge83%
Doctors "always" explained things so they could understand68%
Doctors "always" listened carefully75%
Doctors "always" treated them with courtesy and respect82%
Patients who gave a rating of "9" or "10" (high)72%
Staff "always" explained new medications67%
Nurses "always" explained things so they could understand68%
Nurses "always" listened carefully70%
Nurses "always" treated them with courtesy and respect80%
"Always" quiet at night55%
"YES", patients would definitely recommend the hospital72%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms84%

Original Medicare doctor bills

$32,586

Medicare paid this office $32,586 for 206 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)71$9,451$102
Return visit (30+ min)32$3,502$85
Long return visit (40+ min)19$3,088$147
Injection of drug into eye17$1,611$89
Short return visit (20+ min)19$1,462$73
See all 7 services
Every Original Medicare service billed
Return visit (30+ min)71$9,451$102
Return visit (30+ min)32$3,502$85
Long return visit (40+ min)19$3,088$147
Injection of drug into eye17$1,611$89
Short return visit (20+ min)19$1,462$73
Short return visit (20+ min)12$765$59
Imaging of retina24$645$23

Procedures year by year

Procedures billed to Original Medicare by year
Procedure201920202021202220232024
Injection of drug into eye5852–––18

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

206 Original Medicare patients in 2024. Average age 73 · Under 65 10% · 85 and older 9% · Women 67% · Also on Medicaid 36% · Health risk score 1.41. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.

Conditions among them: High blood pressure 57% · Diabetes 31% · Chronic kidney disease 23% · Depression 18% · Coronary heart disease 17% · Cancer 16% · Atrial fibrillation 16% · Heart failure 10% · COPD 7% · Stroke 7% · Dementia 6%.

The office billed $209,088, Medicare allowed $44,272 and paid $32,586; for 397 services of 32 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024206397731.41$209,088$32,586
2023148269731.19$123,295$21,508
2022129227741.19$89,190$15,035
2021127229741.16$97,109$15,538
2020140234721.61$94,478$16,270
2019140229721.52$114,059$19,536
201887155721.47$90,466$15,812
201786141721.29$85,966$14,669
201672149731.10$87,666$15,693
201571142721.28$69,073$13,140
201453119731.32$61,639$11,821
201343103751.19$47,042$9,604

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 5 services

Original Medicare services billed in 2023
Return visit (30+ min)69$11,595$104
Long return visit (40+ min)19$4,018$161
Imaging of optic nerve34$382$11
Imaging of retina12$235$18
Exam of visual field with extended testing15$188$13

2022: 5 services

Original Medicare services billed in 2022
Return visit (30+ min)48$8,235$113
Established patient complete exam of visual system27$1,963$73
Exam of visual field with extended testing36$631$18
Imaging of optic nerve37$459$12
Imaging of retina17$255$14

2021: 6 services

Original Medicare services billed in 2021
Established patient complete exam of visual system43$8,208$108
New patient complete exam of visual system14$1,925$138
Return visit (30+ min)16$1,753$110
Exam of visual field with extended testing34$705$20
Imaging of optic nerve43$615$14
Imaging of retina15$284$18

2020: 5 services

Original Medicare services billed in 2020
Established patient complete exam of visual system38$6,877$104
Injection of drug into eye41$5,056$97
Imaging of retina33$697$20
Exam of visual field with extended testing21$367$17
Imaging of optic nerve20$356$18

2019: 5 services

Original Medicare services billed in 2019
Established patient complete exam of visual system42$9,337$112
Injection of drug into eye38$4,773$82
Exam of visual field with extended testing16$412$26
Imaging of optic nerve19$390$21
Imaging of retina11$263$24

2018: 2 services

Original Medicare services billed in 2018
Established patient complete exam of visual system57$11,521$112
Injection of drug into eye21$2,194$84

2017: 2 services

Original Medicare services billed in 2017
Established patient complete exam of visual system55$9,815$107
Exam of visual field with extended testing11$301$23

2016: 2 services

Original Medicare services billed in 2016
Established patient complete exam of visual system49$9,797$111
New patient complete exam of visual system23$2,985$130

2015: 3 services

Original Medicare services billed in 2015
Established patient complete exam of visual system41$6,368$114
Established patient problem focused exam of visual system24$2,884$80
Exam of visual field with extended testing12$341$26

2014: 2 services

Original Medicare services billed in 2014
Established patient complete exam of visual system31$6,892$121
Established patient problem focused exam of visual system22$2,668$78

2013: 2 services

Original Medicare services billed in 2013
Established patient complete exam of visual system26$5,372$110
Established patient problem focused exam of visual system15$1,754$80

Medicaid work

$17,464 in 2024

Medicaid paid $17,464 for 263 billed services this clinician did in 2024, up to 26 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Intravitreal injection of a pharmacologic agent (separate procedure)43$8,752
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT29$3,862
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina94$2,523
Service27$1,797
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST41$309
Short return visit (20+ min)14$134
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient15$86
Medicaid work by year
2024263726$17,464
2023327534$43,083
2022929758$42,583
2021564639$14,385
2020622432$10,434
2019461629$4,746
201859116$144
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Hospital outpatient clinic visit for assessment and management of a patient138$33,001
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST59$4,440
Service44$2,929
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina57$1,628
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient29$1,085

2022

Largest Medicaid services in 2022
Hospital outpatient clinic visit for assessment and management of a patient228$36,889
Service206$2,912
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina272$1,233
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient57$781
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST39$363
Return visit (30+ min)99$282
Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2)28$123

2021

Largest Medicaid services in 2021
Hospital outpatient clinic visit for assessment and management of a patient124$11,392
Intravitreal injection of a pharmacologic agent (separate procedure)84$1,542
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina282$1,452
Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2)16$0
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT18$0
OFF/OP EST MAY X REQ PHY/QHP40$0

2020

Largest Medicaid services in 2020
Hospital outpatient clinic visit for assessment and management of a patient100$7,577
Intravitreal injection of a pharmacologic agent (separate procedure)129$2,424
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina221$368
OFF/OP EST MAY X REQ PHY/QHP172$67

2019

Largest Medicaid services in 2019
Intravitreal injection of a pharmacologic agent (separate procedure)81$3,124
Hospital outpatient clinic visit for assessment and management of a patient94$1,188
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST123$273
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina73$97
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve12$65
OFF/OP EST MAY X REQ PHY/QHP78$0

2018

Largest Medicaid services in 2018
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST59$144

Drugs they prescribed that Part D paid

$110,190

Pharmacies billed $110,190 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 1,151) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.

628 generic and 523 brand-name prescriptions · $110,190 in drug cost · 27 antibiotic prescriptions to 20 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Xiidra36$30,431$845
Restasis19$12,943$681
Cyclosporine44$9,460$215
Rhopressa26$8,996$346
Brimonidine90$4,118$46
See all 21 drugs
Every Part D drug this clinician prescribed
Xiidra36$30,431$845
Restasis19$12,943$681
Cyclosporine44$9,460$215
Rhopressa26$8,996$346
Brimonidine90$4,118$46
Prednisolone Acetate63$3,311$53
Loteprednol Etabonate15$3,207$214
Latanoprost290$2,439$8
Fluorometholone20$2,336$117
Dorzolamide-Timolol11$1,931$176
Dorzolamide-Timolol94$1,347$14
Metronidazole24$1,323$55
Dorzolamide75$811$11
Erythromycin43$595$14
Timolol Maleate72$540$7
Valacyclovir33$529$16
Moxifloxacin24$420$18
Polymyxin B Sul-Trimethoprim44$358$8
Neomycin-Polymyxin-Dexameth19$219$12
Azithromycin17$92$5
Acyclovir12$72$6

Year by year

Part D prescribing by year
20241,1512900% (0)45%$110,190
20231,2402790% (0)42%$132,667
20221,3412970% (0)44%$168,644
20211,0682240% (0)46%$137,206
20208881920% (0)41%$166,802
20196491590% (0)39%$58,504
2018316720% (0)44%$21,937
201728569None47%$25,599
201625462None47%$20,459
2015176510% (0)51%$14,485
2014159540% (0)45%$8,760
20132391400% (0)None$10,199

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 19 drugs

Part D drugs prescribed in 2023
Xiidra37$31,376$848
Restasis27$25,907$960
Brimonidine173$12,280$71
Cyclosporine19$9,547$502
Rhopressa18$8,124$451
Latanoprost354$7,008$20
Prednisolone Acetate63$3,969$63
Timolol Maleate162$2,984$18
Tafluprost12$2,695$225
Dorzolamide91$2,398$26
Dorzolamide-Timolol68$1,731$25
Fluorometholone12$954$80
Doxycycline Hyclate14$905$65
Ketorolac Tromethamine12$504$42
Valacyclovir11$392$36
Polymyxin B Sul-Trimethoprim32$312$10
Moxifloxacin12$205$17
Erythromycin13$173$13
Azithromycin16$135$8

2022: 15 drugs

Part D drugs prescribed in 2022
Restasis51$41,956$823
Rhopressa29$11,783$406
Xiidra14$9,468$676
Latanoprost397$7,095$18
Zioptan22$6,884$313
Brimonidine142$6,738$47
Prednisolone Acetate82$5,570$68
Alphagan P11$5,519$502
Timolol Maleate179$3,615$20
Dorzolamide108$2,849$26
Dorzolamide-Timolol73$2,058$28
Pilocarpine12$980$82
Ketorolac Tromethamine25$606$24
Polymyxin B Sul-Trimethoprim38$300$8
Doxycycline Hyclate11$124$11

2021: 16 drugs

Part D drugs prescribed in 2021
Restasis27$21,478$795
Xiidra15$9,272$618
Rhopressa26$8,983$345
Latanoprost334$7,766$23
Brimonidine108$4,916$46
Zioptan18$4,085$227
Prednisolone Acetate55$4,057$74
Dorzolamide89$3,544$40
Timolol Maleate153$2,685$18
Metronidazole16$1,610$101
Dorzolamide-Timolol37$909$25
Doxycycline Hyclate14$793$57
Ketorolac Tromethamine16$538$34
Moxifloxacin15$425$28
Polymyxin B Sul-Trimethoprim22$172$8
Azithromycin15$141$9

2020: 13 drugs

Part D drugs prescribed in 2020
Brimonidine111$7,533$68
Rhopressa12$5,940$495
Travatan Z14$4,823$344
Latanoprost252$4,373$17
Timolol Maleate133$4,176$31
Prednisolone Acetate54$3,075$57
Dorzolamide74$3,011$41
Zioptan13$2,897$223
Dorzolamide-Timolol39$1,913$49
Acetazolamide14$1,709$122
Pilocarpine11$753$68
Doxycycline Hyclate14$495$35
Polymyxin B Sul-Trimethoprim13$133$10

2019: 13 drugs

Part D drugs prescribed in 2019
Restasis12$12,965$1,080
Brimonidine73$5,202$71
Latanoprost153$4,545$30
Timolol Maleate111$3,068$28
Prednisolone Acetate43$2,975$69
Zioptan11$2,393$218
Dorzolamide61$2,221$36
Pilocarpine11$788$72
Dorzolamide-Timolol16$605$38
Doxycycline Hyclate12$277$23
Azithromycin11$145$13
Polymyxin B Sul-Trimethoprim11$111$10
Levobunolol13$96$7

2018: 8 drugs

Part D drugs prescribed in 2018
Xiidra11$5,798$527
Latanoprost75$1,829$24
Prednisolone Acetate20$1,572$79
Brimonidine24$982$41
Dorzolamide32$726$23
Timolol Maleate57$604$11
Dorzolamide-Timolol12$171$14
Levobunolol11$136$12

2017: 7 drugs

Part D drugs prescribed in 2017
Travatan Z17$4,366$257
Brimonidine19$2,076$109
Latanoprost73$1,849$25
Prednisolone Acetate15$1,435$96
Timolol Maleate49$468$10
Dorzolamide18$281$16
Azithromycin18$160$9

2016: 7 drugs

Part D drugs prescribed in 2016
Blephamide21$4,888$233
Travatan Z15$2,267$151
Latanoprost48$883$18
Prednisolone Acetate13$757$58
Dorzolamide16$279$17
Timolol Maleate31$234$8
Azithromycin18$225$12

2015: 4 drugs

Part D drugs prescribed in 2015
Travatan Z14$1,792$128
Latanoprost39$473$12
Timolol Maleate25$291$12
Azithromycin13$170$13

2014: 6 drugs

Part D drugs prescribed in 2014
Patanol12$1,948$162
Prednisolone Acetate16$1,069$67
Dorzolamide-Timolol17$567$33
Latanoprost33$562$17
Azithromycin17$435$26
Timolol Maleate15$144$10

2013: 8 drugs

Part D drugs prescribed in 2013
Blephamide15$2,411$161
Bacitracin12$749$62
Prednisolone Acetate30$710$24
Latanoprost29$663$23
Neomycin-Polymyxin-Dexameth32$636$20
Dorzolamide-Timolol14$432$31
Polymyxin B Sul-Trimethoprim22$241$11
Acyclovir12$236$20

Money from drug and device companies

$144 in 2025

Industry payments by year
202511None$144
202412None$217

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
GenentechSusvimo$144
1 payment
  • Meals for Susvimo · 2025-07-17 · $144
See the published payment
Every published payment
GenentechMeals · 2025-07-17Susvimo$144
See earlier years (2024)

2024: $217

Payments by company in 2024
AmgenTepezza$217
2 payments
  • Meals for Tepezza · 2024-11-19 · $70
  • Meals for Tepezza · 2024-11-19 · $147

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
91.9 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1245334606
Licence
CA A95474California A95474: Current · expires 2027-11-30
Group
UCSF Medical Group Business Services · Regents of the University of California · University of California Sfgh Medical Group
Gender
Female
More record details
Sole proprietor
Yes
Taxonomy
Federal specialty code 207W00000X (207W00000X)
Mailing address
129 Sandringham South, Moraga, CA, 94556
NPI first listed
2006-09-07
NPI last updated
2007-07-08

This is when the NPI record was last certified, not a medical board exam.